Bitopertin is an investigational agent and is not approved for use as a therapy in any jurisdiction worldwide. Disc obtained global rights to bitopertin under a license agreement from Roche in May ...
By: Phone Min Thant, Staff Writer Welcome to Simon Fraser University. You are yet another facility students pay dearly for, only to find out that you are still recovering from the damages of your ...
Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardiometabolic diseases, ...
"Students in the 2023 cohort have not experienced national school and college closures during their 2-year courses of study, but we know they have experienced some disruption. "That’s why we ...